Bridging the Gap Between Participants and Clinical Trials
FB102-701: Severe to Very Severe Alopecia Areata
CONDITION
Skin
GENDER
All
AGE GROUP
From 18
to 75 years
STATUS
Not yet recruiting
FB102-701: A Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Safety and Efficacy of FB102 in Patients with Severe to Very Severe Alopecia Areata